Om

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company focused on developing pharmaceutical products using its lipid nanocrystal (LNC) delivery technology. The company’s platform is designed to support the delivery of a range of therapeutic modalities, including small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its current work has centered on anti-infective applications, including MAT2203, an oral formulation of amphotericin B, alongside additional discovery programs in oncology and inflammation. Matinas BioPharma Holdings, Inc. operates from Bedminster, New Jersey and remains positioned as a developer of novel drug-delivery solutions within the healthcare and biotechnology market.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I MATINAS BIOPHARMA HOLDINGS MED ENDAVU: Køb Matinas BioPharma Holdings ($MTNB) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Matinas BioPharma Holdings, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.